Physician profile
Hyojin Lee
NPI 1437615978
$1,399.57
in general payments reported to CMS, 2019-2025
16 companies · $214 in 2025
The $214 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $76.07 · 2022: $421 · 2023: $323 · 2024: $365 · 2025: $214.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $902.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $902.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $404.18 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $250.46 | 2021-2025 | Zerbaxa, Dificid, Recarbrio |
| Edwards Lifesciences Corporation | $127.22 | 2024 | Hemosphere |
| Astellas Pharma US INC | $120.94 | 2022-2023 | Cresemba |
| Mallinckrodt Hospital Products INC. | $89.80 | 2024 | Terlivaz |
| La Jolla Pharmaceutical Company | $82.20 | 2025 | Giapreza |
| Teleflex LLC | $57.13 | 2022 | |
| Alexion Pharmaceuticals, INC. | $54.34 | 2023 | Ultomiris |
| Eisai INC. | $47.07 | 2022-2024 | |
| Astrazeneca Pharmaceuticals LP | $41.22 | 2022-2024 | Andexxa |
| Takeda Pharmaceuticals U.S.A., INC. | $29.92 | 2021 | |
| Medtronic, INC. | $25.31 | 2025 | Signia |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $22.85 | 2022 | |
| Intercept Pharmaceuticals, INC. | $16.55 | 2025 | |
| Avanos Medical | $15.81 | 2023 | Cortrak |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $14.57 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hyojin Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.